Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
XGNthis companyExagen Inc.	$6.32	-6.54×	7.51×	1.97×	-9.25×	-277.8%	58.3%	-21.1%	-30.0%	-114.3%	-30.0%	-10.9%	1.47×	0.48×	-3.26×	3.45×	0.0%	3	-4.42	1	D+
ACRSAclaris Therapeutics, Inc.	$4.19	-5.68×	3.58×	47.18×	-5.45×	-122.2%	73.3%	-975.9%	-829.6%	-63.0%	-57.7%	-12.8%	0.02×	0.28×	0×	5.28×	0.0%	2	-2.65	1	D+
BIOABioAge Labs Inc.	$5.43	-5.91×	1.75×	52.85×	-3.66×	53.5%	100.0%	-1031.5%	-896.1%	-29.6%	-33.4%	-17.3%	0.02×	2.3×	-133.11×	14.24×	0.0%	3	4.79	2	C+
LFCRLifecore Biomedical, Inc.	$6.39	-8.89×	-19.16×	2.1×	48.19×	-281.7%	31.4%	-1.0%	-23.8%	216.8%	-0.6%	2.3%	-10.04×	15.18×	0.57×	3.49×	0.0%	4	-0.14	1	C-
NEONeoGenomics, Inc.	$17.37	-14×	1.8×	2.07×	-15.87×	-168.7%	38.8%	-9.1%	-14.9%	-12.9%	-5.1%	-1.4%	0.56×	-8.08×	-17.61×	4.26×	0.0%	4	2.5	1	C-
SGHTSight Sciences, Inc.	$10.38	-10.72×	6.47×	5.35×	-11.05×	-82.2%	86.2%	-48.0%	-49.7%	-60.1%	-35.4%	-7.2%	0.64×	1.56×	-7.21×	10.22×	0.0%	4	1.35	1	C-
Peer median	—	-8.89×	1.8×	5.35×	-5.45×	-122.2%	73.3%	-48.0%	-49.7%	-29.6%	-33.4%	-7.2%	0.02×	1.56×	-7.21×	5.28×	0.0%	4	1.35	1	—